Annette Tumolo - Jul 20, 2022 Form 4 Insider Report for Codex DNA, Inc. (TBIO)

Role
Director
Signature
/s/ Rob Cutler, as Attorney-in-Fact
Stock symbol
TBIO
Transactions as of
Jul 20, 2022
Transactions value $
$0
Form type
4
Date filed
7/22/2022, 04:38 PM
Previous filing
Nov 15, 2021
Next filing
May 3, 2024

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TBIO Stock Option (right to buy) Award $0 +112K $0.00 112K Jul 20, 2022 Common Stock 112K $1.93 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Codex DNA, Inc.'s (the "Issuer") Common Stock. Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Sock Incentive Plan) through each such date, one third (1/3rd) of the RSUs shall vest annually following the Grant Date on the same day of the month as the Grant Date over three (3) years. "Grant Date" shall mean July 20, 2022.
F2 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan) through each applicable vesting date, one thirty-sixth (1/36th) of the Shares subject to the Option shall vest in equal monthly installments following the Grant Date on the same day of the month as the Grant Date. "Grant Date" shall mean July 20, 2022.